Objective: The aim of this study was to determine the seroprevalence of HBsAg, anti-HCV and anti-HIV by evaluating the serologic screening results in blood donors who applied to Transfusion Center of Batman State Regional Hospital between 2008 and 2010.
Methods: The donor questionnaire was filled by blood donors ranging between 18-60 years of age, and a physical examination was carried out. The screening tests were performed on non-risk applicants. HBsAg, anti-HCV antibody and anti-HIV 1/2 + p24 antigen tests were performed by using microparticle enzyme immunoassay (MPEIA) (Architect i2000 SR, Abbott, Germany).
Results: Routine screening tests were applied to 3316 blood donors. The tests were positive for HbsAg in 64 (1.9%) donors, and in 3 (0.1%) donors for anti-HCV. No HIV seropositivity was found.
Conclusions: Seropositivity rate of blood donors admitted to our transfusion center is lower than the general seropositivity rates of Turkey. Klimik Dergisi 2011; 24(3): 173-5.
Key Words: Blood donors, hepatitis B surface antigens, hepatitis C antibodies, HIV antibodies.
Article in Turkish
(Use the link for full-text in Turkish)